The aim of the work is increasing of safety of anesthesiologic management of patients suffering from breast cancer with high risk of cardiovascular complications and decreasing of complicatioons rate due to providing patency of upper airways with larengeal mask airway I-gel.
Larengeal mask airway I-gel usage cause the lesser reaction on the cardiovascular system with compared hermetic indices. The obtained data allow to recommend larengeal mask airway I-gel usage when conducting a total intravenous anesthesia with artificial lung ventilation in planned surgery of breast cancer in patients with high risk of cardiovascular complications as a choice method for providing patency of upper airways.